Lyra Therapeutics, Inc.

NasdaqGM:LYRA Stock Report

Market Cap: US$11.8m

Lyra Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of LYRA?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders332,3200.508%
Hedge Funds4,772,8167.29%
Institutions15,732,96624%
VC/PE Firms18,645,97828.5%
General Public25,973,56839.7%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 24.5%.


Top Shareholders

Top 25 shareholders own 58.58% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
19.5%
Perceptive Advisors LLC
12,757,562US$2.3m0%0.05%
9%
North Bridge Venture Partners
5,888,416US$1.1m0%2.62%
7.29%
Citadel Advisors LLC
4,772,816US$862.0k0%no data
4.57%
BlackRock, Inc.
2,993,626US$540.6k5.78%no data
4.25%
Samsara BioCapital LLC
2,780,261US$502.1k0%0.06%
2.72%
The Vanguard Group, Inc.
1,779,263US$321.3k2.79%no data
1.61%
Ikarian Capital, LLC
1,056,829US$190.9k0%0.05%
1.52%
SEI Investments Company
997,782US$180.2k0%no data
1.17%
Geode Capital Management, LLC
768,388US$138.8k1.76%no data
0.96%
Nantahala Capital Management, LLC
628,073US$113.4k-77.7%0.01%
0.78%
Eaton Vance Management
512,482US$92.6k-33.1%no data
0.75%
State Street Global Advisors, Inc.
488,720US$88.3k88.1%no data
0.7%
Two Sigma Advisers, LP
460,300US$83.1k-32.5%no data
0.69%
Goldman Sachs Asset Management, L.P.
451,789US$81.6k0%no data
0.43%
Two Sigma Investments, LP
282,547US$51.0k-42.4%no data
0.4%
Harlan Waksal
261,966US$47.3k0%no data
0.39%
Everhart Financial Group, Inc.
252,708US$45.6k0%0.01%
0.36%
Boothbay Fund Management, LLC
232,670US$42.0k0%no data
0.28%
Northern Trust Global Investments
183,284US$33.1k119%no data
0.24%
ExodusPoint Capital Management, LP
159,238US$28.8k0%no data
0.24%
New York State Common Retirement Fund
154,800US$28.0k-59.6%no data
0.21%
Morgan Stanley, Investment Banking and Brokerage Investments
139,899US$25.3k207%no data
0.18%
BMO Asset Management Corp.
119,379US$21.6k0%no data
0.17%
Charles Schwab Investment Management, Inc.
111,609US$20.2k0%no data
0.17%
Acadian Asset Management LLC
110,493US$20.0k-88.8%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/27 14:18
End of Day Share Price 2024/12/27 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Lyra Therapeutics, Inc. is covered by 9 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jason Matthew GerberryBofA Global Research
Justin ZelinBTIG
null nullBTIG